Northeast Tiger Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2014. For the period, the company may record a significant decrease in net profit and will record loss as compared to that of the corresponding period in 2013.
1st Jan change | Capi. | |
---|---|---|
+34.14% | 5.87B | |
-30.04% | 3.71B | |
+1.55% | 3.17B | |
-22.68% | 2.71B | |
-8.17% | 2.36B | |
+42.02% | 1.89B | |
+45.22% | 1.5B | |
-12.58% | 1.44B | |
+40.95% | 1.35B |